- Presentations
- 4
- Markets
- 1
Invega Trinza is a brand of Paliperidone palmitate marketed by Janssen Pharmaceuticals, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Paliperidone palmitate
- Brand owner
- Janssen Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 310.227 mg/1 mL extended-release injectable suspension, 310.606 mg/1 mL extended-release injectable suspension, 311.407 mg/1 mL extended-release injectable suspension, 312 mg/1 mL extended-release injectable suspension
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Invega Trinza 310.227 mg/1 mL extended-release injectable suspensionIntramuscular | Janssen Pharmaceuticals | US FDA | Available on request |
| Invega Trinza 310.606 mg/1 mL extended-release injectable suspensionIntramuscular | Janssen Pharmaceuticals | US FDA | Available on request |
| Invega Trinza 311.407 mg/1 mL extended-release injectable suspensionIntramuscular | Janssen Pharmaceuticals | US FDA | Available on request |
| Invega Trinza 312 mg/1 mL extended-release injectable suspensionIntramuscular | Janssen Pharmaceuticals | US FDA | Available on request |
Equivalent brands
Other brands of Paliperidone palmitate.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Invega Trinza
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.